Project Grant HT9425261E104
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- Federal Grant Award Summary The University of Michigan's Regents received a $1.84 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on co-targeting NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. This research initiative represents a translational oncology effort designed to advance...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $1.7 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year performance period running from July 1, 2026, through June 30, 2029. The award funds research focused on targeted disruption of the ARP300 enhanceosome in prostate cancer using domain-alteration chimeras (DALTACs), representing...
- The Department of Defense's Defense Health Agency awarded a $1,100,747 Project Grant on April 1, 2025 to the Regents of the University of Michigan to conduct research on "Protein Engineering of Antibody-Drug Conjugates to Coordinate the Innate and Adaptive Immune Systems for Curative Responses" under the Military Medical Research and Development program (CFDA 12.420). This research aims to develop innovative medical solutions that address critical health challenges relevant to military...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $559,046 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2028. The award funds research investigating biased protein phosphatase 2A heterotrimerization in the development and treatment of uveal melanoma. This hypothesis-driven research initiative is expected to advance understanding of...
- Federal Grant Award Summary The University of Michigan's Regents, through its Office of Research and Sponsored Projects Division, received a $537,536 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The research initiative, titled "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment," will be conducted...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects has received a $1.396 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2029. The award supports clinical validation of a plasma circulating tumor DNA (ctDNA) assay for diffuse midline glioma (DMG) diagnosis and surveillance. This research initiative contributes to the DHA's...
- The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $405,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2027. The award supports research on retinal repair via viral-mediated endogenous reprogramming of Müller glia cells, conducted at the University of Michigan's Ann Arbor campus. This research initiative...
- This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....